Mon panier

Biotinylated Human GDF-8 Protein, Avitag™

Avis des utilisateurs
Numéro de produit/spécification
Prix
Qté
GD8-H8313-25ug
$365.00
GD8-H8313-200ug
$1449.00
ETA of in-stock products:2 business days
Total des articles Montant du produit$ 0

Détails du produit

  • Synonyms

    GDF-8, Myostatin, GDF8, MSTN, Growth, differentiation factor 8

  • Source

    Biotinylated Human GDF-8 Protein, Avitag (GD8-H8313) is expressed from CHO cells. It contains AA Asp 267 - Ser 375 (Accession # O14793-1).

    Predicted N-terminus: Asp 267

    Request for sequence
  • Molecular Characterization

    GDF-8 Structure

    Other Tags and Version Biotin & Other Labeled Version

    This protein carries an Avi tag (Avitag™) at the C-terminus.

    The protein has a calculated MW of 14.4 kDa. The protein migrates as 13-15 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.

  • Labeling

    Biotinylation of this product is performed using Avitag™ technology. Briefly, the single lysine residue in the Avitag is enzymatically labeled with biotin.

  • Protein Ratio

    Passed as determined by the HABA assay / binding ELISA.

  • Purity

    >90% as determined by SDS-PAGE.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in 50 mM HAC, pH3.0 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Les clients ont également consulté

Affichage des données

  • SDS-PAGE

    GDF-8 SDS-PAGE

    Biotinylated Human GDF-8 Protein, Avitag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90% (With Star Ribbon Pre-stained Protein Marker).

  • Bioactivity-ELISA

     GDF-8 ELISA

    Immobilized Biotinylated Human GDF-8 Protein, Avitag (Cat. No. GD8-H8313) at 0.1 μg/mL (100 μL/well) on streptavidin (Cat. No. STN-N5116) precoated (0.5 μg/well) plate can bind Human Activin RIIB, His Tag (Cat. No. ACB-H5226) with a linear range of 2-78 ng/mL (QC tested).

    Protocol
  •  GDF-8 ELISA

    Immobilized Biotinylated Human GDF-8 Protein, Avitag (Cat. No. GD8-H8313) at 0.1 μg/mL (100 μL/well) on streptavidin (Cat. No. STN-N5116) precoated (0.5 μg/well) plate can bind Human Follistatin Protein, Fc Tag (Cat. No. FON-H5256) with a linear range of 0.3-10 ng/mL (Routinely tested).

    Protocol
  • Bioactivity-SPR

     GDF-8 SPR

    Human Follistatin Protein, His Tag, premium grade (Cat. No. FON-H52H4) immobilized on CM5 Chip can bind Biotinylated Human GDF-8 Protein, Avitag (Cat. No. GD8-H8313) with an affinity constant of 1.71 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).

    Protocol

Avis des utilisateurs
Publier un commentaire

Introduction de fond

This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate each subunit of the disulfide-linked homodimer. This protein negatively regulates skeletal muscle cell proliferation and differentiation. Mutations in this gene are associated with increased skeletal muscle mass in humans and other mammals. [provided by RefSeq, Jul 2016]

Progrès de frontière

 
Progrès du développement médicamenteux
  • Nom anglais:

    Growth/differentiation factor 8

  • Catégorie:

  • Nombre de médicaments répertoriés:

    0 Détails

  • Nombre de médicaments cliniques:

    8 Détails

  • Étape de développement la plus élevée:

    NDA/BLA

Drug Candidate Licensing
More
  • Informations de base sur le produit
  • Détails du produit
  • Les clients ont également consulté
  • Affichage des données
  • Avis des utilisateurs
  • Contexte